timesofisrael.com

Turkey’s Antitrust Watchdog Launches Probe of Teva Over Rival Generic Blocking

Teva Pharmaceutical Industries logoTeva Pharmaceutical Industries
Sig2.95Sen-3.60Env0.00Soc0.00Gov-4.75

Turkey’s Competition Authority has opened an antitrust investigation into Teva over allegations that it blocked rival generic medicines. The probe follows a preliminary inquiry into whether Teva engaged in conduct meant to restrict competition, including practices tied to divisional patent applications. The case also comes amid Teva’s prior EU antitrust fine in 2024 related to Copaxone.

Coverage (1)

ABOUT

What is Fimmer?

Most feeds treat all company headlines the same. An executive interview, an office closure, stock analysis, and a data breach can sit side by side with no sense of scale. Fimmer ranks coverage by what matters, so important events stand out and signals are prioritised over noise. We cluster related company news and score each story using a range of metrics, so you see the most crucial stories first.

SCORING

What do the scores mean?

Significance (0–10) measures the scale of the real-world impact. Sentiment and ESG (−10 to +10) indicate the tone of the coverage and whether the change relates to environmental, social, or governance factors. Together, these scores help distinguish meaningful developments from routine company news. More information about our scoring methodology can be found on our About page.

DISCOVERY

Explore more on Fimmer

Search more than 10,000 public companies, browse the company index, explore their scores, and read the coverage behind them, with our core features available to everyone for free.

For more advanced features, Pro gives you access to dynamic feeds, custom sorting, and more ways to track the companies that matter to you.

More with Pro